Accès ouvert
2025
article
OpenAlex
Giuseppe Morgia, Arturo Lo Giudice, Sebastiano Cimino, Giulio Reale et autres
Introduction: Historically, medical therapy of BPH has had its foundations in alpha-blockers in monotherapy or in combination with 5 alpha reductase inhibitors (5-ARIs); in particular, two important trials (COMBAT and MTOPS) have demonstrated the pivotal role of combination therapy instead of monotherapy …
it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Giovannino Ciccone, Stefano De Luca, Marco Oderda, F. Muñoz et autres
Importance: Although active surveillance for patients with low-risk prostate cancer (LRPC) has been recommended for years, its adoption at the population level is often limited. Objective: To make active surveillance available for patients with LRPC using a research framework and to compare …
it, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Claudia Manini, E. López-Anglada Fernández, Nicola Cruciano, Alessandro Comandone et autres
The correct diagnosis of mesothelial proliferations is a classic problem for pathologists, and one which has important clinical implications. A significant number of such cases appear associated with recurrent hydrocele, as an irritative/reactive response to this condition. The morphological spectrum of mesothelial …
it, es
(code pays fourni par la source)